Genes in panel
Regions in panel
Prev Next

Regression

Gene: KCTD7

Green List (high evidence)

KCTD7 (potassium channel tetramerization domain containing 7, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000243335
EnsemblGeneIds (GRCh37): ENSG00000243335
OMIM: 611725, ClinGen, DECIPHER
KCTD7 is in 17 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Mutations in the KCTD7 gene cause a severe neurodegenerative phenotype characterized by onset of intractable myoclonic seizures before age 2 years and accompanied by developmental regression.
Created: 7 Dec 2022, 1:53 p.m. | Last Modified: 7 Dec 2022, 1:53 p.m.
Panel Version: 0.513

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions (MIM#611726)

History Filter Activity

7 Dec 2022, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: kctd7 has been classified as Green List (High Evidence).

7 Dec 2022, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: KCTD7 were changed from to Epilepsy, progressive myoclonic 3, with or without intracellular inclusions (MIM#611726)

7 Dec 2022, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: KCTD7 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

18 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: KCTD7 was added gene: KCTD7 was added to Regression_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: KCTD7 was set to Unknown